CAT and Parkinson disease: In the same direction, Kojima and colleagues [203], in 2018, designed intracerebrally implanted human mesenchymal stem cells, able to deliver into PD mice brain exosomes enriched with therapeutic catalase mRNA, which, once delivered and translated in target cells, attenuates neurotoxicity and neuroinflammation [203].